Before paying any company to bank adipose tissue, a patient should be able to verify its claims against public, independent sources. The tissue banking field includes serious operators and questionable ones, and the difference is checkable. This guide gives a practical verification process: what to confirm, where to confirm it, and the marketing language that should make a patient pause.
TLDR: A legitimate tissue banking company can be verified against public sources before a patient pays. Confirm FDA establishment registration through the FDA’s public database, identify and check the laboratory partner and its accreditation, require transparent itemized pricing, watch for marketing red flags, and confirm chain-of-custody and storage documentation. One critical point: FDA registration is an administrative listing, not FDA approval, and any company implying otherwise is a warning sign. Banking preserves a person’s own tissue for potential future use; it is not a treatment and does not guarantee eligibility, access, or clinical benefit.
Important Disclaimer: Save My Fat does not provide FDA-approved treatments or cures for any disease or condition. Banking adipose tissue today does not guarantee eligibility, access, or clinical benefit from any future therapy, clinical trial, or medical program. All content is for educational purposes only and does not constitute medical advice. Patients must consult their own licensed healthcare professionals regarding all medical decisions.
Verification protects a patient’s money and trust. The checks below each reference a publicly verifiable source, so a patient is not relying on a company’s own marketing to evaluate it.
Why Verification Matters in Tissue Banking
Tissue banking is a long-term commitment, often involving years of storage, so the credibility of the company matters well beyond the first payment. Because the field is marketed aggressively and the science is easy to overstate, a patient benefits from checking claims independently rather than trusting promotional language. Verification is not cynicism; it is ordinary diligence for a service a patient may rely on for years.
The good news is that the most important facts are checkable through public sources. The overview of how to spot fake stem cell clinics covers warning signs in the therapy context, and many of the same principles apply to banking companies. A legitimate company will welcome verification and provide documentation, while an evasive one is itself a warning sign.
Check 1: FDA Establishment Registration
Establishments that recover, process, store, or distribute human cells and tissues must register with the FDA and comply with current good tissue practice requirements. A patient can verify registration directly through the FDA’s Human Cell and Tissue Establishment Registration public query on fda.gov, which lists registered establishments.
The single most important caveat is that FDA registration is not FDA approval. Registration is an administrative listing, and the FDA has explicitly cautioned that it does not signify a seal of quality, safety, or endorsement. Any company that markets itself as FDA approved, or that blurs registration into approval, is misrepresenting its status, and that is a serious red flag. The overview of FDA establishment registration explains the distinction in more detail.
Check 2: Laboratory Partner Identity and Accreditation
A legitimate banking company is transparent about where tissue is actually processed and stored. If a company will not identify its laboratory partner, that opacity is a warning sign. Save My Fat, for example, identifies its laboratory partner as L2 Bio and operates under 21 CFR Part 1271, and the overview of L2 Bio processing describes how tissue is handled after transfer.
Beyond identity, a patient can ask about accreditation and standards. Compliance with current good tissue practice under 21 CFR Part 1271 is the baseline, and additional accreditation, such as accreditation by the American Association of Tissue Banks, is worth asking about. A patient should request documentation of a company’s and its laboratory partner’s regulatory status rather than accepting a general assurance.
Check 3: Pricing Transparency and What Is Included
Transparent, itemized pricing is a mark of a legitimate service. A patient should be able to see what the initial cost covers, what ongoing storage costs, and what any future retrieval would involve, without hidden or shifting fees. Pricing that is vague, evasive, or accompanied by pressure to commit quickly is a warning sign.
The overview of adipose tissue banking explains what the service generally includes, which gives a patient a baseline for evaluating any company’s pricing. The goal is to understand exactly what is being purchased before signing, not to discover costs later.
Check 4: Marketing Language Red Flags
Marketing language is often the clearest signal. Claims of miracle results, promised outcomes, or assured access to clinical trials are not consistent with what banking actually is, which is preservation. A company using such language is either misinformed or misleading, and either is a reason for caution.
The table below summarizes common red flags and what a legitimate service does instead.
| Red flag to watch for | What a legitimate service does instead |
|---|---|
| Claims to be “FDA approved” | States it is FDA registered under 21 CFR Part 1271 and explains registration is not approval |
| Promises specific treatment outcomes or miracle results | Describes banking as preservation, with no outcome promised |
| Claims stored tissue secures trial access | Explains banking does not create trial eligibility |
| Uses pressure tactics or artificial urgency | Gives patients time and transparent information |
| Hidden, vague, or shifting pricing | Provides clear, itemized pricing and what is included |
| Will not name its laboratory partner | Identifies its processing and storage facility |
| No chain-of-custody documentation | Documents chain-of-custody and storage conditions |
Check 5: Chain-of-Custody and Storage Documentation
Chain-of-custody documentation tracks tissue from collection through storage, and it is a core part of operating responsibly under federal tissue regulations. A patient should confirm that a company documents the handling and transfer of tissue, applies unique patient identifiers, and can describe its storage conditions and monitoring.
A legitimate company can explain how it maintains storage, including temperature monitoring and backup systems, and what documentation a patient receives. The overview of choosing a provider covers what to look for. Documentation a patient can review is far more reassuring than a verbal assurance.
Questions to Ask Before You Sign
A short list of questions helps a patient evaluate any company before committing. A patient can ask for the company’s FDA establishment registration and how to verify it, the identity of the laboratory partner and its accreditation, itemized pricing including storage and retrieval, and a description of chain-of-custody and storage documentation. A patient can also ask the company to confirm in writing that banking is preservation and does not guarantee any treatment, trial access, or outcome.
The answers should be specific and verifiable. A company that answers clearly and points to public sources is behaving as a legitimate operator should, while one that deflects or substitutes marketing for documentation is showing a patient what to expect.
Frequently Asked Questions
Does FDA registration mean a banking company is FDA approved?
No. FDA registration is an administrative listing of establishments that handle human tissue, not a seal of approval, quality, or endorsement. The FDA has explicitly cautioned that registration does not equal approval, and any company implying otherwise is misrepresenting its status.
How do I verify a company’s FDA registration?
A patient can search the FDA’s Human Cell and Tissue Establishment Registration public query on fda.gov, which lists registered establishments. Confirming registration is a basic, public check before paying.
What marketing language should make me cautious?
Claims of miracle results, promised outcomes, or assured clinical trial access are not consistent with what banking is. Pressure tactics and artificial urgency are also warning signs. Legitimate companies describe banking as preservation with no outcome promised.
Should a company name its laboratory partner?
Yes. A legitimate company is transparent about where tissue is processed and stored. If a company will not identify its laboratory partner, that opacity is a warning sign.
How is adipose tissue banking regulated?
Banked adipose tissue is handled under 21 CFR Part 1271, the federal framework governing screening, processing, and storage of human cells and tissues, including current good tissue practice requirements.
Key Takeaways
For patients vetting a banking company, the essential facts are public and checkable before any payment. Confirm FDA establishment registration through the FDA’s public database while understanding that registration is an administrative listing and not FDA approval, identify and verify the laboratory partner and its accreditation, require transparent itemized pricing, watch for marketing red flags such as miracle-result claims and promised trial access, and confirm chain-of-custody and storage documentation. A company that welcomes verification and points to public sources is behaving as a legitimate operator should. Above all, banking adipose tissue is a preservation service for potential future use; it is not a treatment, and it does not guarantee eligibility, access, or clinical benefit.
Save My Fat operates as a tissue preservation service, not a medical practice or treatment provider. Stem cell and regenerative medicine regulations vary by state, including specific informed-consent and disclosure requirements in Florida, Utah, and Nevada governing tissue and stem cell services. Banking adipose tissue does not connect patients to any treatment pathway, and any future use depends on FDA regulatory status, physician guidance, and the availability of approved or investigational pathways at that time.
Patients evaluating a banking company can review what a transparent service looks like and contact the team with questions.
Save My Fat partners with L2 Bio for laboratory processing and storage.
This article is for educational purposes only and does not constitute medical or legal advice. Legal and medical review is required before publication. Please consult your physician before making any decisions about banking, treatment, or research participation.
